Akorn (AKRX)

14.85 +0.02  +0.13%  May 22, 12:39PM
Add to Watchlists Create an Alert

Akorn Revenue Quarterly YoY Growth:

42.80% for Dec. 31, 2012
View Full Chart

Akorn Revenue Quarterly YoY Growth Chart

    Akorn Historical Revenue Quarterly YoY Growth Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 3   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 67.79%
    Sept. 30, 2012 89.72%
    June 30, 2012 96.86%
    March 31, 2012 103.3%
    Dec. 31, 2011 77.27%
    Sept. 30, 2011 69.46%
    June 30, 2011 59.27%
    March 31, 2011 24.00%
    Dec. 31, 2010 32.26%
    Sept. 30, 2010 11.81%
    June 30, 2010 23.83%
    March 31, 2010 -6.90%
    Dec. 31, 2009 -30.17%
    Sept. 30, 2009 -39.23%
    June 30, 2009 -23.22%
    March 31, 2009 52.43%
    Dec. 31, 2008 89.93%
    Sept. 30, 2008 101.6%
    June 30, 2008 82.41%
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About Revenue Growth

    Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.

    If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
    Learn More

    Get data for

    AKRX Revenue Quarterly YoY Growth Benchmarks

    Companies
    Mylan 3.02%
    Dr. Reddy Laboratories -0.19%
    Teva Pharmaceutical Industries -3.94%

    AKRX Revenue Quarterly YoY Growth Rankings

    Overall 94th percentile
    463 of 8005
    Sector 86th percentile
    90 of 686 in Healthcare
    Industry 85th percentile
    10 of 68 in Drug Manufacturers - Specialty & Generic

    AKRX Revenue Quarterly YoY Growth Range, Past 5 Years

    Minimum -39.23% Sep 2009
    Maximum 103.3% Mar 2012
    Average 46.44%